FDA flags liver injury risk tied to Amgen Tavneos, citing drug-induced liver injury and rare vanishing bile duct syndrome complications.
Importance Rank:
1
FDA flags liver injury risk tied to Amgen Tavneos, citing drug-induced liver injury and rare vanishing bile duct syndrome complications.
Copyright © Louis Velazquez. All Rights Reserved.